BAX - Baxter International Inc.

NYSE - NYSE Delayed Price. Currency in USD
81.73
-0.54 (-0.66%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close 82.27
Open 82.00
Bid 0.00 x 800
Ask 81.74 x 1800
Day's Range 81.67 - 82.66
52 Week Range 61.05 - 82.80
Volume 1,899,371
Avg. Volume 2,663,329
Market Cap 41.696B
Beta (3Y Monthly) 1.07
PE Ratio (TTM) 27.88
EPS (TTM) 2.93
Earnings Date Jul 25, 2019
Forward Dividend & Yield 0.88 (1.07%)
Ex-Dividend Date 2019-06-06
1y Target Est 82.93
Trade prices are not sourced from all markets
  • Top Analyst Reports for ExxonMobil, Oracle & ADP
    Zacks 5 days ago

    Top Analyst Reports for ExxonMobil, Oracle & ADP

    Top Analyst Reports for ExxonMobil, Oracle & ADP

  • No, The China Trade War Isn't Coming For Your Medicine — Here's Why
    Investor's Business Daily 5 days ago

    No, The China Trade War Isn't Coming For Your Medicine — Here's Why

    President Trump's threats to ratchet up tariffs on goods from China will have a minimal impact on biotech companies, experts say. Meanwhile, medtech companies dodged tariffs in Mexico.

  • Business Wire 9 days ago

    Baxter Highlights Renal Care Data about Patients’ Health-Related, Quality of Life Outcomes at the 56th ERA-EDTA Congress

    Baxter International Inc. (BAX), a global innovator in renal care, showcased 19 data presentations on therapy options at the 56th ERA-EDTA Congress, Budapest, Hungary, June 13-16. The presentations spanned the renal care continuum, from chronic kidney disease (CKD) management to peritoneal dialysis (PD) and hemodialysis (HD).

  • Here's Why You Should Hold Baxter International (BAX) for Now
    Zacks 9 days ago

    Here's Why You Should Hold Baxter International (BAX) for Now

    Baxter (BAX) expects its bottom line to rise in the second quarter of 2019, courtesy to Renal Care and Clinical Nutrition businesses.

  • Business Wire 12 days ago

    Baxter Leads Hemodialysis Research Consortium for German Federal Ministry of Education and Research

    Baxter International Inc. (BAX), a global innovator in renal care, today announced receipt of a major research and development (R&D) grant from the German Federal Ministry of Education and Research (BMBF)’s “From Material to Innovation” program to lead a consortium investigating an anticoagulation-free hemodialysis (HD) option for end-stage renal disease (ESRD) patients. The grant provides €1.5 million in funding over three years to Baxter’s research team in Hechingen, Germany, and the consortium partners to find a solution that will improve health-related, quality-of-life outcomes for the millions of patients receiving HD therapy globally.

  • Business Wire 15 days ago

    Baxter to Host Second Quarter 2019 Financial Results Conference Call for Investors

    Baxter International Inc. (BAX), a leading global medical products company, will host a conference call to discuss its second quarter 2019 financial results on Thursday, July 25, 2019, at 7:30 a.m. Central Time. The Conference ID is 2089733.

  • Baxter Launches Sharesource 2.0 Telehealth Platform to Support Greater Clinical Insights and Personalized Peritoneal Dialysis Care
    Business Wire 15 days ago

    Baxter Launches Sharesource 2.0 Telehealth Platform to Support Greater Clinical Insights and Personalized Peritoneal Dialysis Care

    DEERFIELD, Ill.-- -- Enhancements designed to give healthcare providers access to more comprehensive treatment data and improve clinic workflow New study further supports value of remote patient management technology to personalize dialysis treatments, reduce alarms and in-person visits, while saving clinicians and patients significant time Baxter International Inc. , a global innovator in renal care, ...

  • Business Wire 22 days ago

    The Baxter International Foundation Commits $2 Million+ to Operation Smile Care Centers in India

    The Baxter International Foundation, the philanthropic arm of Baxter International Inc. (BAX), announced today a $2.2 million grant to Operation Smile, one of the world’s largest volunteer-based surgical nonprofit organizations, to deliver free surgical and multidisciplinary care to underserved communities in India. During the next three years, the grant will support Operation Smile’s year-round care centers in Mumbai, Srinagar and Bangalore—operated in partnership with the Inga Health Foundation—along with a new care center in Durgapur, West Bengal.

  • Business Wire 29 days ago

    Baxter Announces New Research on 3-in-1 Oxiris Set for CRRT and Sepsis Management

    Baxter International Inc. (BAX), a global leader in acute care therapies, announced today that the peer-reviewed journal Blood Purification published a supplemental issue sponsored by Baxter that features real-world clinical experience with the company’s Oxiris filter, which can be used simultaneously in continuous renal replacement therapy (CRRT) and in the removal of cytokines and endotoxin to aide in the management of acute kidney injury (AKI) patients with sepsis. The studies, which are being highlighted at the 37th Vicenza Course on AKI and CRRT in Italy this week, add to the body of scientific knowledge around the use of extracorporeal (outside the body) blood purification (EBP) to address critical conditions.

  • Baxter (BAX) Down 1.5% Since Last Earnings Report: Can It Rebound?
    Zacks last month

    Baxter (BAX) Down 1.5% Since Last Earnings Report: Can It Rebound?

    Baxter (BAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Top Research Reports for Cigna, EOG Resources & Northrop Grumman
    Zacks 2 months ago

    Top Research Reports for Cigna, EOG Resources & Northrop Grumman

    Top Research Reports for Cigna, EOG Resources & Northrop Grumman

  • Barrons.com 2 months ago

    3 Stocks That Hiked Their Dividends This Week

    Synchrony Financial announced before the opening bell Thursday that it will increase its quarterly dividend by a penny, following dividend increases by Phillips 66 and Baxter International.

  • Business Wire 2 months ago

    Baxter to Conduct Fixed Income Investor Presentations

    Baxter International Inc. (BAX), a leading global medical products company, today announced that representatives of the company will conduct a series of Fixed Income Investor Presentations on Thursday, May 9, 2019.

  • Baxter International Inc. (NYSE:BAX) Delivered A Better ROE Than Its Industry
    Simply Wall St. 2 months ago

    Baxter International Inc. (NYSE:BAX) Delivered A Better ROE Than Its Industry

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Many investors are still learning about the various metrics that can be useful when analysing a stock...

  • BAX vs. CLPBY: Which Stock Is the Better Value Option?
    Zacks 2 months ago

    BAX vs. CLPBY: Which Stock Is the Better Value Option?

    BAX vs. CLPBY: Which Stock Is the Better Value Option?

  • Business Wire 2 months ago

    Baxter Named a “Best Company for Multicultural Women” by Working Mother

    Baxter International Inc. (BAX), a leading global medical products company, announced today that it has been named a 2019 Best Company for Multicultural Women by Working Mother magazine. This recognition is a result of the company’s sustained focus on supporting and advancing multicultural women at all levels of the organization globally.

  • Business Wire 2 months ago

    Baxter Increases Dividend and Declares Quarterly Dividend

    Baxter International Inc. , a leading global medical products company, today announced an increase in the company’s quarterly cash dividend, to a rate of $0.22 per share of common stock.

  • Markit 2 months ago

    See what the IHS Markit Score report has to say about Baxter International Inc.

    Baxter International Inc NYSE:BAXView full report here! Summary * Perception of the company's creditworthiness is negative * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is extremely low for BAX with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting BAX. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $673 million over the last one-month into ETFs that hold BAX are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swap | NegativeThe current level displays a negative indicator. BAX credit default swap spreads are near their highest levels of the last 3 years, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Business Wire 2 months ago

    Baxter to Present at the UBS Global Healthcare Conference

    Baxter International Inc. (BAX), a leading global medical products company, will present at the UBS Global Healthcare Conference on Monday, May 20, 2019 in New York. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 1:00 p.m. Eastern Time.

  • Thomson Reuters StreetEvents 2 months ago

    Edited Transcript of BAX earnings conference call or presentation 25-Apr-19 12:30pm GMT

    Q1 2019 Baxter International Inc Earnings Call

  • Business Wire 2 months ago

    Baxter, NAACP and the Alliance for Home Dialysis Expand Program to Increase Awareness of Kidney Care among African Americans

    Baxter International Inc. (BAX), a global leader in renal care, along with the National Association for the Advancement of Colored People (NAACP) and the Alliance for Home Dialysis, today announced that the Dialysis Health Imperative for Access, Choice, and Equity (ACE) program will be expanded for a third year. This year, the program is expected to reach even more individuals and focus on driving awareness of kidney disease—including risk factors, prevention strategies and home dialysis treatment options—among the African American community.

  • Baxter International Inc (BAX) Q1 2019 Earnings Call Transcript
    Motley Fool 2 months ago

    Baxter International Inc (BAX) Q1 2019 Earnings Call Transcript

    BAX earnings call for the period ending March 31, 2018.

  • Baxter International Beats Expectations in Q1
    Motley Fool 2 months ago

    Baxter International Beats Expectations in Q1

    The medical products company delivered a solid performance to start off 2019.

  • Baxter (BAX) Q1 Earnings and Revenues Surpass Estimates
    Zacks 2 months ago

    Baxter (BAX) Q1 Earnings and Revenues Surpass Estimates

    Higher revenues, growth in APAC and strong operating margin benefit Baxter's (BAX) Q1 earnings. However, weak performance at Medication Delivery and Clinical Nutrition remains a concern.

  • Baxter (BAX) Beats on Q1 Earnings and Revenue Estimates
    Zacks 2 months ago

    Baxter (BAX) Beats on Q1 Earnings and Revenue Estimates

    Baxter International Inc. (BAX) reports solid Q1 performance on the back of higher revenues and strong operating margin.